Skip to main content
OpenTrials

Clinical trial condition

Pruritus

Explore clinical trials studying Pruritus. Study availability and eligibility vary by location and protocol.

336 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Pruritus trial results

Completed

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01241591

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations
  • Centro de Investigaciones Dermatologicas Buenos Aires, C1114aap, Argentina
  • Centro de Investigaciones Dermatologicas Buenos Aires, Argentina
  • IMAI (Instituto Medico de Asistencia e Investigaciones) Buenos Aires, Argentina
  • LKH Feldkirch Abteilung fuer Dermatologie und Venerologie Feldkirch, Austria
View all 122 locations
View Trial Details
Completed

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01186744

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations
  • Horizon Research Group, Inc. Mobile, Alabama, United States
  • Radiant Research, Inc. Tucson, Arizona, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Associates In Research, Inc. Fresno, California, United States
View all 87 locations
View Trial Details
Completed

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

NCT01636687

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
  • Novartis Investigative Site Overland Park, Kansas, United States
View all 39 locations
View Trial Details
Completed

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients

NCT02161562

Conditions
Angioedema, Cardiovascular Diseases, Chronic Disease, +16 more
Locations
  • Novartis Investigative Site Pilar, Buenos Aires, Argentina
  • Novartis Investigative Site Santa Fe, Rosario, Argentina
  • Novartis Investigative Site Rosario, Santa Fe Province, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
View all 35 locations
View Trial Details

Related conditions